Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma
纳武利尤单抗联合维布妥昔单抗治疗复发/难治性弥漫性大B细胞淋巴瘤
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2599082
Johnson, Nathalie A; Zinzani, Pier Luigi; Domingo-Domenech, Eva; Brody, Joshua; Kline, Justin; Shah, Bijal Dinesh; Mehta, Amitkumar Nitinkumar; Ghesquieres, Herve; Savage, Kerry J; Barr, Paul M; Santoro, Armando; Ferrari, Silvia; Cunningham, David; Collins, Graham P; Fanale, Michelle; Krajewski, Jennifer; Akyol, Alev; Crowe, Russell; Wen, Rachael; Kuruvilla, John